“You can’t lose what you don’t put in the middle. But you can’t win much either.” - Warren Buffet or maybe that was Mike McDermott At this point is it really gambling though if you know you are going to get paid? Either shorts cover or the price keeps going up every FTD cycle. Buy and Hodl. This thing has been timed and comes through like a chick’s period.
What's the consensus on biotech companies / companies that may or may not be involved in covid-related products? Still a good idea to invest in these, or...?
i wouldn't make generalizations. i think each company needs to be looked at individually, and the company's ability to grow beyond covid needs to be taken into account. the extreme bear case for fulgent is that this company's windfall from covid testing is unsustainable, and it will go back to $16. the bull case is this: 1. covid testing will go down a lot, but won't go away as quickly as some think, to reopen safely you want to keep testing. there are also opporunities overseas, FLGT has a china JV. 2. FLGT is projecting to have $1bn cash by end of year. their cap is only $2.2bn. half the share value will be the cash pile by end of year. lots of room to fund growth. 3. the genetic sequencing biz (which is their core biz before covid) is much smaller but growing at 115% YOY. they recently won a $30m contract from CDC which wasn't included in last qtr's numbers. if you take the enterprise value of the company, its a reasonable valuation for such a high growth comnpany. 4. i think its a super well run company that is great at execution, beating bigger labs in testing speed/cost, hence why CDC trusts them with new contract beyond just covid testing. founder still owns 30% and doesn't sell his shares. to get a flavor check out their latest ridiculous qtr. https://ir.fulgentgenetics.com/news...eports-record-first-quarter-financial-results
I have PFE calls expiring 9.17 that I've been holding forever. Time to cash out? Or exercise and hold? Was hoping it might be insulated from interest rate hikes.
i wrongly expected a red day out of reflex - 2 days of green is not possible! best day trade was IMNM, up 18% on insider buying. last 2 weeks i just screen for insider buying and hit F5 every now and then lol.
@RudyTBag Another one you may want to keep an eye on is CTXR. price has already gone up to $2.30 in anticipation of DMC allowing them to stop the trial for superiority soon. analyst think it can go to $5, but if committee thinks the trial needs to keep going, price will likely go back to $1.50s. people are bullish cos phase 2 had 100% efficacy rate, but of course there's risk, maybe phase 3 reveals complications not uncovered in phase 2 etc. if you are looking to buy check out the DD below first, so you know what you are getting into, and what to do in case phase 3 doesn't stop early and price tanks. https://frugalnorwegian.com/ctxr/
They're all the same strike, up 75%. But it was like 200% after their last ER. I thought I was too late to the PFE party, but the price actually looked pushed down when I bought March 8th ($34ish). Why did I buy? Simply to prevent myself from FOMO-ing myself in the future. I didn't want to feel like I made a mistake and overpay later if it started to run. So I locked in the long call - just in case. Did the same with DNN.
last ERS was ~13 May; despite beating estimate, amid the prevailing fear of inflation, despite assurance from the Fed that it was only transitory, the stock price tanked. now the market appears to believe the Fed's explanation sdgr appears to have bottomed and bounced (~11 pts) off it, leading to 3 consecutive days of closing above 20dma need to see it close above the 50dma, ~ above ~72.5, before making a play for closing the 82-100 gap
Out of CRM @ opening bell and into this bad boy. It’s been a laggard relative to semis and tech in general...playing for a catch up trade. Lisa Su is a beast and the charts look favorable risk/ reward wise. Off to a good start so far today.
This is true..but those are usually when they get those 10...20 mil ones. Plus they released the news at a good time. May 25, 2021 12:45 PM ET (BZ Newswire) -- Long Ideas The stock of Palantir Technologies Inc. may be about to move higher. Over the past week, resistance at the $21.25 level has kept a top on the share price. But the bulls keep chipping away and the resistance seems to be diminishing. If the bulls absorb all of the shares at this level, it will set the stage for a rally as new buyers enter the market. These new buyers will have to pay higher prices if they want to acquire shares. This could force Palantir's stock into a new uptrend.
